Exosome Diagnostics and the Addario Lung Cancer Medical Institute (ALCMI) to Collaborate on Development of Liquid Biopsy Cancer Diagnostics

January 28, 2015 Leave a comment 3,361 Views

Clinical testing underway utilizing matched samples from ALCMI’s Collaborative Advanced Stage Tissue Lung Cancer (CASTLE) Trial Collaboration will support validation for Exosome Diagnostics’ ALK and T790M plasma-based diagnostics planned to launch in 2015 Novel biofluid-based diagnostics offer the potential to ...

Exosome RNA Exosome RNA Research & Industry News

Tag Archives: plasma-based

Exosome Diagnostics and the Addario Lung Cancer Medical Institute (ALCMI) to Collaborate on Development of Liquid Biopsy Cancer Diagnostics

4th GSEV Autumn Meeting, 3 and 4 October

Organicell Announces FDA Approval Of IND Application For The Use Of Zofin™ In COVID-19 Long Haulers

Intelligent Probabilistic System for Digital Tracing Cellular Origin of Individual Clinical Extracellular Vesicles

Exosome-mediated delivery of CRISPR/Cas9 for targeting pancreatic cancer

UH researcher receives NIH grant to detect cancer biomarkers in blood by counting exosomes

Regenerative potential of epicardium-derived extracellular vesicles mediated by conserved miRNA transfer